PubMed:24742750 / 0-265 JSONTXT

{"project":"LitCoin-entities-OrganismTaxon-PD","denotations":[{"id":"T1","span":{"begin":16,"end":21},"obj":"OrganismTaxon"},{"id":"T2","span":{"begin":162,"end":167},"obj":"OrganismTaxon"}],"attributes":[{"id":"A1","pred":"db_id","subj":"T1","obj":"NCBItxid:9606"},{"id":"A2","pred":"db_id","subj":"T2","obj":"NCBItxid:9606"}],"text":"Availability of human induced pluripotent stem cell-derived cardiomyocytes in assessment of drug potential for QT prolongation.\nField potential duration (FPD) in human-induced pluripotent stem cell-derived cardiomyocytes (hiPS-CMs), which can express QT interval in"}

{"project":"LitCoin-sentences","denotations":[{"id":"T1","span":{"begin":0,"end":127},"obj":"Sentence"}],"text":"Availability of human induced pluripotent stem cell-derived cardiomyocytes in assessment of drug potential for QT prolongation.\nField potential duration (FPD) in human-induced pluripotent stem cell-derived cardiomyocytes (hiPS-CMs), which can express QT interval in"}

{"project":"LitCoin-entities","denotations":[{"id":"9878","span":{"begin":16,"end":21},"obj":"OrganismTaxon"},{"id":"9879","span":{"begin":111,"end":126},"obj":"DiseaseOrPhenotypicFeature"},{"id":"9880","span":{"begin":162,"end":167},"obj":"OrganismTaxon"}],"attributes":[{"id":"A1","pred":"db_id","subj":"9878","obj":"NCBITaxon:9606"},{"id":"A2","pred":"db_id","subj":"9879","obj":"MESH:D008133"},{"id":"A3","pred":"db_id","subj":"9880","obj":"NCBITaxon:9606"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"Availability of human induced pluripotent stem cell-derived cardiomyocytes in assessment of drug potential for QT prolongation.\nField potential duration (FPD) in human-induced pluripotent stem cell-derived cardiomyocytes (hiPS-CMs), which can express QT interval in"}

{"project":"LitCoin-GeneOrGeneProduct-v2","denotations":[{"id":"T1","span":{"begin":47,"end":51},"obj":"GeneOrGeneProduct"},{"id":"T2","span":{"begin":193,"end":197},"obj":"GeneOrGeneProduct"}],"text":"Availability of human induced pluripotent stem cell-derived cardiomyocytes in assessment of drug potential for QT prolongation.\nField potential duration (FPD) in human-induced pluripotent stem cell-derived cardiomyocytes (hiPS-CMs), which can express QT interval in"}

{"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T1","span":{"begin":0,"end":12},"obj":"GeneOrGeneProduct"},{"id":"T2","span":{"begin":22,"end":29},"obj":"GeneOrGeneProduct"},{"id":"T3","span":{"begin":47,"end":51},"obj":"GeneOrGeneProduct"},{"id":"T4","span":{"begin":154,"end":157},"obj":"GeneOrGeneProduct"},{"id":"T5","span":{"begin":168,"end":175},"obj":"GeneOrGeneProduct"},{"id":"T6","span":{"begin":193,"end":197},"obj":"GeneOrGeneProduct"}],"text":"Availability of human induced pluripotent stem cell-derived cardiomyocytes in assessment of drug potential for QT prolongation.\nField potential duration (FPD) in human-induced pluripotent stem cell-derived cardiomyocytes (hiPS-CMs), which can express QT interval in"}

{"project":"LitCoin-Disease-MeSH","denotations":[{"id":"T1","span":{"begin":111,"end":126},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"originalLabel","subj":"T1","obj":"DISEASE"}],"text":"Availability of human induced pluripotent stem cell-derived cardiomyocytes in assessment of drug potential for QT prolongation.\nField potential duration (FPD) in human-induced pluripotent stem cell-derived cardiomyocytes (hiPS-CMs), which can express QT interval in"}

{"project":"LitCoin_Mondo_095","denotations":[{"id":"T1","span":{"begin":239,"end":242},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"0012833"}],"text":"Availability of human induced pluripotent stem cell-derived cardiomyocytes in assessment of drug potential for QT prolongation.\nField potential duration (FPD) in human-induced pluripotent stem cell-derived cardiomyocytes (hiPS-CMs), which can express QT interval in"}

{"project":"LitCoin-MeSH-Disease-2","denotations":[{"id":"T1","span":{"begin":111,"end":126},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"ID:","subj":"T1","obj":"DISEASE"}],"text":"Availability of human induced pluripotent stem cell-derived cardiomyocytes in assessment of drug potential for QT prolongation.\nField potential duration (FPD) in human-induced pluripotent stem cell-derived cardiomyocytes (hiPS-CMs), which can express QT interval in"}

{"project":"LitCoin-MONDO_bioort2019","denotations":[{"id":"T1","span":{"begin":111,"end":126},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"#label","subj":"T1","obj":"DISEASE"}],"text":"Availability of human induced pluripotent stem cell-derived cardiomyocytes in assessment of drug potential for QT prolongation.\nField potential duration (FPD) in human-induced pluripotent stem cell-derived cardiomyocytes (hiPS-CMs), which can express QT interval in"}

{"project":"LitCoin-NCBITaxon-2","denotations":[{"id":"T1","span":{"begin":16,"end":21},"obj":"OrganismTaxon"},{"id":"T2","span":{"begin":162,"end":167},"obj":"OrganismTaxon"}],"text":"Availability of human induced pluripotent stem cell-derived cardiomyocytes in assessment of drug potential for QT prolongation.\nField potential duration (FPD) in human-induced pluripotent stem cell-derived cardiomyocytes (hiPS-CMs), which can express QT interval in"}

{"project":"LitCoin-training-merged","denotations":[{"id":"T35311","span":{"begin":111,"end":126},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T14865","span":{"begin":162,"end":167},"obj":"OrganismTaxon"},{"id":"T8106","span":{"begin":16,"end":21},"obj":"OrganismTaxon"}],"attributes":[{"id":"A63857","pred":"#label","subj":"T35311","obj":"DISEASE"}],"text":"Availability of human induced pluripotent stem cell-derived cardiomyocytes in assessment of drug potential for QT prolongation.\nField potential duration (FPD) in human-induced pluripotent stem cell-derived cardiomyocytes (hiPS-CMs), which can express QT interval in"}

{"project":"Allie","denotations":[{"id":"SS1_24742750_1_0","span":{"begin":128,"end":152},"obj":"expanded"},{"id":"SS2_24742750_1_0","span":{"begin":154,"end":157},"obj":"abbr"},{"id":"SS1_24742750_1_1","span":{"begin":162,"end":220},"obj":"expanded"},{"id":"SS2_24742750_1_1","span":{"begin":222,"end":230},"obj":"abbr"}],"relations":[{"id":"AE1_24742750_1_0","pred":"abbreviatedTo","subj":"SS1_24742750_1_0","obj":"SS2_24742750_1_0"},{"id":"AE1_24742750_1_1","pred":"abbreviatedTo","subj":"SS1_24742750_1_1","obj":"SS2_24742750_1_1"}],"text":"Availability of human induced pluripotent stem cell-derived cardiomyocytes in assessment of drug potential for QT prolongation.\nField potential duration (FPD) in human-induced pluripotent stem cell-derived cardiomyocytes (hiPS-CMs), which can express QT interval in"}